Industry Watch
•  AustCancer Completes US Cancer Care Acquisition
•  Biota-Sankyo in Influenza Drug Partnership
•  Eastland Files Patent for Rota-Vax
•  GTG Commercializes Genetic Test for Athletic Performance
•  Meridica Licenses Xcelovair™ to Pfizer
•  Avesthagen Sets Up US Subsidiaries
•  Nicholas Piramal Hunting for Global Partners and Researchers in Therapeutic R&D
•  Cipla Exerts Its Presence in US Market
•  Unichem's Expansion Plans
•  Takeda Sues Mylan, Watson abd Ranbaxy over Patent Infringements
•  Yamanouchi's Vesicare Receives USFDA Approval for Launch
•  TaiGen and TTY Biopharm Co-develop Cancer Treatment Drug

Products/Services Highlight
•  New Radiotherapy Center in Australia
•  Breakthrough in Cardiac Disease Treatment
•  New Prostheses Available in Taiwan

Research Findings
•  Arthron's Proprietary Target Identified as TNFá Regulator
•  Glaucoma - A Growing Concern for Japanese

Rules & Regulations
•  Indian Government Retains Ban on Phase I Drug Trial

Agriculture
•  Increased Popularity of Food Labels among Consumers
•  Biotechnology Offers Solutions for Sustaining Agricultural Growth
•  Avestha Gengraine Granted Patent for New Transgenic Technology
•  Controversy over Regulation of Bt Cotton
•  Japan Prefers Taiwanese Agricultural Produce

General News
•  Australia Embarks on New Biotech Strategy
•  India Formulates Framework Telemedicine
•  India Emerging as Global Clinical Trial Center
•  Indonesia's Policy for Biotechnology
•  Genetic Diagnosis for In Vitro Fertilized Egg Planned
•  Initatives to Boost New Zealand's Biotechnology

Global Development
•  Procyon Secures Patent for Novel Anti-HIV Protease Inhibitors

Conference Calendar